D001813PhysiologyA07.040A09.371.729.055440.996638Blood-Retinal Barrierplugins:TwitterTwitterprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson28523456Mathew B, Poston JN, Dreixler JC, Torres L, Lopez J, Zelkha R, Balyasnikova I, Lesniak MS, Roth SGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle OphthalmologieBone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in rats. Graefes Arch Clin Exp Ophthalmol. 2017 Aug; 255(8):1581-1592.Graefes Arch Clin Exp Ophthalmol2017-05-18T00:00:002017Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in rats.0.3252310.03870764research area of0.3263280.1009793subject area forAnesthesia and Critical CareOphthalmology and Visual Sciencehttp://ophthalmology.uchicago.eduThe University of Chicago Department of Ophthalmologyhttps://www.uchicagomedicine.org/forefront/microbiome-articles/2018/december/looking-for-links-between-the-gut-microbiome-and-eye-diseaseLooking for links between the gut microbiome and eye diseasehttps://ophthalmology.uchicago.edu/news/featured-faculty-fridays-dimitra-skondra-md-phdFeatured Faculty Fridays: Dimitra Skondra, MD, PhDhttps://www.uchicagomedicine.org/forefront/research-and-discoveries-articles/2017/september/experimental-treatment-for-macular-holes-opts-for-eye-drops-over-surgeryExperimental treatment for macular holes opts for eye drops over surgeryUChicagoOVSUniversity of ChicagoJohn C.DreixlerJohn C. Dreixler41.78927490000000-87.601250000000001086Dreixler, John C.Research Associate ProfessorBijiMathewBiji Mathew41.78927490000000-87.601250000000001936Mathew, BijiStevenRothSteven Roth41.78927490000000-87.60125000000000563Roth, StevenEmeritus/Emerita, Professortrue1true1Research Associate ProfessorResearch Associate Professortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professortrue1Associate ProfessorAssociate Professor20939800Yilmaz T, Cordero-Coma M, Lavaque AJ, Gallagher MJ, Padula WVCurrent pharmaceutical biotechnologyTriamcinolone and intraocular sustained-release delivery systems in diabetic retinopathy. Curr Pharm Biotechnol. 2011 Mar 01; 12(3):337-46.Curr Pharm Biotechnol2011-03-01T00:00:002011Triamcinolone and intraocular sustained-release delivery systems in diabetic retinopathy.AnesthesiologyDimitraSkondraDimitra Skondra0.000000000000000.000000000000003387Skondra, DimitraAssociate Professor18235021Skondra D, Noda K, Almulki L, Tayyari F, Frimmel S, Nakazawa T, Kim IK, Zandi S, Thomas KL, Miller JW, Gragoudas ES, Hafezi-Moghadam AInvestigative ophthalmology & visual scienceCharacterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown. Invest Ophthalmol Vis Sci. 2008 Feb; 49(2):726-31.Invest Ophthalmol Vis Sci2008-02-01T00:00:002008Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.